Developing pathogen reduction technologies for RBC suspensions.


Numerous studies have evaluated a wide variety of photosensitizers and alkylating agents as candidates for a pathogen reduction process to be used in RBC suspensions. The methodologies that produce robust inactivation of pathogens with maintenance of RBC properties during storage involve those that specifically target nucleic acids. This has been… (More)
DOI: 10.1111/j.1423-0410.2010.01386.x


Cite this paper

@article{Wagner2011DevelopingPR, title={Developing pathogen reduction technologies for RBC suspensions.}, author={Stephen Wagner}, journal={Vox sanguinis}, year={2011}, volume={100 1}, pages={112-21} }